Notify me when Gagnon Advisors, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 24 | $161,954,292 | +$23,287,682 | -$17,310,419 | +$5,977,263 | AMRC, WGS, FRSH, AL, EPD | 13F-HR | 03 Nov 2025, 15:31 |
| Q2 2025 | 24 | $148,814,264 | +$15,815,852 | -$26,845,136 | -$11,029,284 | WGS, PSIX, AL, EPD, CDNA | 13F-HR | 23 Jul 2025, 16:37 |
| Q1 2025 | 28 | $141,789,200 | +$13,851,531 | -$9,071,238 | +$4,780,293 | EPD, WGS, AL, PSIX, CDNA | 13F-HR | 12 May 2025, 09:35 |
| Q4 2024 | 26 | $156,191,331 | +$8,490,037 | -$28,265,613 | -$19,775,576 | WGS, PSIX, EPD, AL, CDNA | 13F-HR | 23 Jan 2025, 18:11 |
| Q3 2024 | 27 | $154,842,696 | +$8,936,807 | -$11,223,931 | -$2,287,124 | PSIX, CDNA, WGS, EPD, AL | 13F-HR | 12 Nov 2024, 06:00 |
| Q2 2024 | 27 | $131,346,135 | +$12,493,523 | -$3,296,314 | +$9,197,209 | EPD, CDNA, AL, NVGS, AOSL | 13F-HR | 14 Aug 2024, 13:00 |
| Q1 2024 | 27 | $115,263,592 | +$12,282,160 | -$9,937,338 | +$2,344,822 | AL, EPD, NVGS, BL, FIVN | 13F-HR | 13 May 2024, 17:15 |
| Q4 2023 | 26 | $114,479,578 | +$5,569,458 | -$14,209,979 | -$8,640,521 | AL, NVGS, EPD, FIVN, BL | 13F-HR | 14 Feb 2024, 17:14 |
| Q3 2023 | 28 | $119,536,528 | +$377,082 | -$13,114,400 | -$12,737,318 | AL, NVGS, EPD, ETWO, PROF | 13F-HR | 14 Nov 2023, 16:05 |
| Q2 2023 | 29 | $149,441,189 | +$4,696,535 | -$3,310,929 | +$1,385,606 | NVGS, AL, ETWO, NEWR, EPD | 13F-HR | 08 Aug 2023, 17:25 |
| Q1 2023 | 28 | $148,971,677 | +$10,165,893 | -$15,830,516 | -$5,664,623 | NVGS, AL, NEWR, ETWO, EPD | 13F-HR | 10 Apr 2023, 16:15 |
| Q4 2022 | 29 | $148,156,414 | +$2,444,076 | -$12,640,501 | -$10,196,425 | APEN, NVGS, AL, EPD, AMRC | 13F-HR | 07 Feb 2023, 16:41 |
| Q3 2022 | 32 | $154,430,000 | +$12,160,628 | -$18,924,984 | -$6,764,356 | NVGS, AMRC, PCRX, EPD, EVA | 13F-HR | 14 Nov 2022, 16:40 |
| Q2 2022 | 33 | $165,106,000 | +$7,738,057 | -$5,567,187 | +$2,170,870 | PCRX, NVGS, AL, EPD, EVA | 13F-HR | 01 Aug 2022, 16:29 |
| Q1 2022 | 33 | $217,085,000 | +$25,467,278 | -$26,457,269 | -$989,991 | PCRX, AMRC, AL, NVGS, EVA | 13F-HR | 09 May 2022, 17:08 |
| Q4 2021 | 34 | $251,685,000 | +$12,149,616 | -$12,184,758 | -$35,142 | AOSL, PCRX, AMRC, NEWR, AL | 13F-HR | 08 Feb 2022, 16:05 |
| Q3 2021 | 35 | $252,105,000 | +$40,081,525 | -$32,426,296 | +$7,655,229 | CDNA, BL, AMRC, AOSL, PCRX | 13F-HR | 12 Nov 2021, 16:39 |
| Q2 2021 | 32 | $263,102,000 | +$16,699,163 | -$24,855,419 | -$8,156,256 | CDNA, AMRC, BL, FIVN, AOSL | 13F-HR | 28 Jul 2021, 13:53 |
| Q1 2021 | 30 | $242,888,000 | +$22,102,705 | -$9,237,203 | +$12,865,502 | CDNA, AMRC, AOSL, PCRX, BL | Restatement | 28 Jul 2021, 13:51 |
| Q4 2020 | 29 | $222,461,000 | +$7,466,471 | -$4,557,000 | +$2,909,471 | CDNA, AMRC, BL, FIVN, AOSL | 13F-HR | 12 Feb 2021, 16:15 |
| Q3 2020 | 29 | $161,314,000 | +$14,473,595 | -$837,268 | +$13,636,327 | AMRC, CDNA, PCRX, BL, FIVN | 13F-HR | 12 Nov 2020, 16:10 |
| Q2 2020 | 26 | $138,944,000 | +$3,735,029 | -$14,500,705 | -$10,765,676 | AMRC, CDNA, BL, PCRX, NEWR | Restatement | 14 Aug 2020, 16:37 |
| Q1 2020 | 27 | $107,167,000 | +$8,828,211 | -$38,495,794 | -$29,667,583 | AMRC, CDNA, BL, PCRX, ONTO | 13F-HR | 11 May 2020, 16:05 |
| Q4 2019 | 32 | $178,379,000 | +$8,556,033 | -$31,323,543 | -$22,767,510 | AL, AMRC, GFN, EVBG, NVGS | 13F-HR | 14 Feb 2020, 16:07 |
| Q3 2019 | 32 | $161,282,000 | +$5,227,988 | -$5,714,459 | -$486,471 | AL, AMRC, EQIX, GFN, EVBG | 13F-HR | 08 Nov 2019, 16:10 |
| Q2 2019 | 33 | $175,183,000 | +$12,922,756 | -$9,961,236 | +$2,961,520 | EVBG, CDNA, AL, AMRC, EQIX | 13F-HR | 12 Aug 2019, 16:05 |
| Q1 2019 | 33 | $174,791,000 | +$28,224,613 | -$15,347,580 | +$12,877,033 | CDNA, AMRC, EVBG, AL, GFN | 13F-HR | 13 May 2019, 16:10 |
| Q4 2018 | 31 | $142,288,000 | +$16,467,761 | -$13,666,749 | +$2,801,012 | CDNA, RHT, GFN, AMRC, AL | 13F-HR | 18 Jan 2019, 16:11 |
| Q3 2018 | 30 | $166,888,000 | +$8,807,437 | -$16,375,388 | -$7,567,951 | CDNA, GFN, RHT, AMRC, AL | 13F-HR | 13 Nov 2018, 17:21 |
| Q2 2018 | 29 | $157,967,000 | +$13,707,535 | -$16,720,230 | -$3,012,695 | GFN, CDNA, RHT, NEWR, AL | 13F-HR | 09 Aug 2018, 16:28 |
| Q1 2018 | 31 | $134,384,000 | +$4,217,479 | -$16,704,455 | -$12,486,976 | GFN, RHT, AL, AMRC, CDNA | 13F-HR | 09 May 2018, 17:11 |
| Q4 2017 | 30 | $136,423,000 | +$4,709,326 | -$6,808,024 | -$2,098,698 | GFN, AL, FIVN, RHT, CDNA | 13F-HR | 13 Feb 2018, 14:49 |
| Q3 2017 | 29 | $128,425,000 | +$13,872,207 | -$11,977,082 | +$1,895,125 | GFN, FIVN, AL, RTEC, AMRC | 13F-HR | 14 Nov 2017, 12:21 |
| Q2 2017 | 27 | $115,944,000 | +$12,343,962 | -$9,343,581 | +$3,000,381 | GFN, AL, RHT, AMRC, FIVN | 13F-HR | 20 Jul 2017, 14:54 |
| Q1 2017 | 27 | $107,173,000 | +$228,588 | -$16,127,780 | -$15,899,192 | AL, GFN, LLFLQ, RHT, RTEC | 13F-HR | 11 May 2017, 16:38 |
| Q4 2016 | 27 | $118,610,000 | +$7,007,577 | -$18,862,779 | -$11,855,202 | AL, GFN, RTEC, RHT, AOSL | 13F-HR | 14 Feb 2017, 16:33 |
| Q3 2016 | 28 | $126,648,000 | +$19,840,575 | -$12,063,768 | +$7,776,807 | RTEC, AL, AOSL, RHT, GFN | 13F-HR | 14 Nov 2016, 16:34 |
| Q2 2016 | 26 | $110,347,000 | +$17,156,986 | -$18,851,488 | -$1,694,502 | RTEC, AL, RHT, EQIX, ATHN | Restatement | 24 Aug 2016, 10:24 |
| Q1 2016 | 23 | $113,370,000 | +$6,735,736 | -$21,298,344 | -$14,562,608 | AL, EQIX, RTEC, GFN, RHT | 13F-HR | 03 May 2016, 15:44 |
| Q4 2015 | 23 | $135,075,000 | +$3,136,300 | -$5,254,866 | -$2,118,566 | RHT, ATHN, EQIX, AL, RTEC | 13F-HR | 16 Feb 2016, 11:50 |
| Q3 2015 | 23 | $122,917,000 | +$8,544,305 | -$5,499,382 | +$3,044,923 | RHT, EQIX, ATHN, AL, RTEC | 13F-HR | 16 Oct 2015, 11:16 |
| Q2 2015 | 23 | $146,059,000 | +$6,783,359 | -$2,632,949 | +$4,150,410 | RHT, EQIX, AL, GFN, ATHN | 13F-HR | 24 Jul 2015, 10:47 |
| Q1 2015 | 24 | $115,699,000 | +$9,598,360 | -$5,547,769 | +$4,050,591 | GFN, EQIX, AL, CTCT, PSIX | 13F-HR | 12 May 2015, 17:27 |
| Q4 2014 | 23 | $166,116,000 | +$18,432,269 | -$20,520,966 | -$2,088,697 | GFN, EQIX, RHT, ATHN, CTCT | 13F-HR | 13 Feb 2015, 14:06 |
| Q3 2014 | 26 | $161,755,000 | +$12,227,971 | -$701 | +$12,227,270 | GFN, EQIX, ATHN, AL, RHT | 13F-HR | 15 Oct 2014, 16:26 |
| Q2 2014 | 24 | $159,969,000 | +$6,339,011 | -$22,489,090 | -$16,150,079 | GFN, AL, EQIX, CTCT, ATHN | 13F-HR | 31 Jul 2014, 15:01 |
| Q1 2014 | 28 | $176,537,000 | +$20,433,306 | -$27,657,156 | -$7,223,850 | GFN, AL, ATHN, EQIX, RHT | 13F-HR | 06 May 2014, 16:24 |
| Q4 2013 | 28 | $172,838,000 | $0 | $0 | $0 | NVDQ, GFN, ATHN, AL, RHT | 13F-HR | 06 Feb 2014, 16:02 |